Cargando…
Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792840/ https://www.ncbi.nlm.nih.gov/pubmed/36582466 http://dx.doi.org/10.3389/fcell.2022.1081151 |
| _version_ | 1784859721654599680 |
|---|---|
| author | SH, Slight SM, Hyder |
| author_facet | SH, Slight SM, Hyder |
| author_sort | SH, Slight |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9792840 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97928402022-12-28 Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? SH, Slight SM, Hyder Front Cell Dev Biol Cell and Developmental Biology Frontiers Media S.A. 2022-12-13 /pmc/articles/PMC9792840/ /pubmed/36582466 http://dx.doi.org/10.3389/fcell.2022.1081151 Text en Copyright © 2022 SH and SM. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cell and Developmental Biology SH, Slight SM, Hyder Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| title | Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| title_full | Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| title_fullStr | Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| title_full_unstemmed | Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| title_short | Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| title_sort | should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target? |
| topic | Cell and Developmental Biology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792840/ https://www.ncbi.nlm.nih.gov/pubmed/36582466 http://dx.doi.org/10.3389/fcell.2022.1081151 |
| work_keys_str_mv | AT shslight shouldoxidosqualenecyclaseinthecholesterolbiosyntheticpathwaybeconsideredananticancertarget AT smhyder shouldoxidosqualenecyclaseinthecholesterolbiosyntheticpathwaybeconsideredananticancertarget |